This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 2019 Oct;58(10):1208-1211.

doi: 10.1007/s00120-019-01038-2.

[Tumor treatment of metastatic renal cell carcinoma : Comparison of immunotherapy with other drug options]

[Article in German]

A Uhlig^{1

2}

Affiliations

Affiliations

¹ Klinik für Urologie, Universitätsmedizin Göttingen, Göttingen, Deutschland. uroevidence@dgu.de.
² UroEvidence@Deutsche Gesellschaft für Urologie, Nestorstraße 8/9, 10709, Berlin, Deutschland. uroevidence@dgu.de.

PMID: 31471642
DOI: 10.1007/s00120-019-01038-2

Review

[Tumor treatment of metastatic renal cell carcinoma : Comparison of immunotherapy with other drug options]

[Article in German]

A Uhlig. Urologe A. 2019 Oct.

. 2019 Oct;58(10):1208-1211.

doi: 10.1007/s00120-019-01038-2.

Author

A Uhlig^{1

2}

Affiliations

¹ Klinik für Urologie, Universitätsmedizin Göttingen, Göttingen, Deutschland. uroevidence@dgu.de.
² UroEvidence@Deutsche Gesellschaft für Urologie, Nestorstraße 8/9, 10709, Berlin, Deutschland. uroevidence@dgu.de.

PMID: 31471642
DOI: 10.1007/s00120-019-01038-2

No abstract available

PubMed Disclaimer

Similar articles

Metastatic renal cell carcinoma: systemic treatment.
Abi-Aad AS, deKernion JB. Abi-Aad AS, et al. Acta Urol Belg. 1996 May;64(2):3-8. Acta Urol Belg. 1996. PMID: 8701805 Review. No abstract available.
Medical treatment options in patients with metastatic renal cell carcinoma.
Haferkamp A, Hohenfellner M. Haferkamp A, et al. Nephrol Dial Transplant. 2007 Apr;22(4):996-9. doi: 10.1093/ndt/gfl734. Epub 2007 Jan 8. Nephrol Dial Transplant. 2007. PMID: 17210591 Review. No abstract available.
Role of cytokine therapy in 2006 and beyond for metastatic renal cell cancer.
Parton M, Gore M, Eisen T. Parton M, et al. J Clin Oncol. 2006 Dec 10;24(35):5584-92. doi: 10.1200/JCO.2006.08.1638. J Clin Oncol. 2006. PMID: 17158544 Review.
Combination immunotherapy in metastatic renal cell carcinoma. Are we leaving something back?
Di Nunno V, Gatto L, Fragomeno B, Cubelli M, Nobili E, Romano I, Santoni M, Pisconti S, Montironi R, Massari F. Di Nunno V, et al. Future Oncol. 2018 Dec;14(29):2997-2999. doi: 10.2217/fon-2018-0604. Epub 2018 Nov 9. Future Oncol. 2018. PMID: 30411632 No abstract available.
Integrative tumor board: metastatic renal cell carcinoma: medical oncology.
Gupta SK, Vogelzang N. Gupta SK, et al. Integr Cancer Ther. 2004 Mar;3(1):26-9. doi: 10.1177/1534735403261846. Integr Cancer Ther. 2004. PMID: 15035871 No abstract available.

See all similar articles

References

1. Can J Urol. 2008 Apr;15(2):3954-66 - PubMed
1. Clin Cancer Res. 2010 Nov 15;16(22):5539-47 - PubMed
1. Biometrics. 1994 Dec;50(4):1088-101 - PubMed
1. Curr Probl Cancer. 1997 Jul-Aug;21(4):185-232 - PubMed
1. Eur Urol Oncol. 2019 Jul;2(4):343-348 - PubMed

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Springer
Medical
- MedlinePlus Health Information